Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients.
Oliveira LB, Mwangi VI, Sartim MA, Delafiori J, Sales GM, de Oliveira AN, Busanello ENB, Val FFAE, Xavier MS, Costa FT, Baía-da-Silva DC, Sampaio VS, de Lacerda MVG, Monteiro WM, Catharino RR, de Melo GC.
Oliveira LB, et al.
Front Microbiol. 2022 Apr 27;13:844283. doi: 10.3389/fmicb.2022.844283. eCollection 2022.
Front Microbiol. 2022.
PMID: 35572676
Free PMC article.